JP2018512874A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018512874A5 JP2018512874A5 JP2017555218A JP2017555218A JP2018512874A5 JP 2018512874 A5 JP2018512874 A5 JP 2018512874A5 JP 2017555218 A JP2017555218 A JP 2017555218A JP 2017555218 A JP2017555218 A JP 2017555218A JP 2018512874 A5 JP2018512874 A5 JP 2018512874A5
- Authority
- JP
- Japan
- Prior art keywords
- expression vector
- pharmaceutical composition
- mammal
- kdm4d
- hyperplasia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021045410A JP7325466B2 (ja) | 2015-04-20 | 2021-03-19 | 再生医療のためのベクターおよび方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562150159P | 2015-04-20 | 2015-04-20 | |
| US62/150,159 | 2015-04-20 | ||
| PCT/US2016/028459 WO2016172224A1 (en) | 2015-04-20 | 2016-04-20 | Vectors and methods for regenerative therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021045410A Division JP7325466B2 (ja) | 2015-04-20 | 2021-03-19 | 再生医療のためのベクターおよび方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018512874A JP2018512874A (ja) | 2018-05-24 |
| JP2018512874A5 true JP2018512874A5 (enExample) | 2019-05-23 |
| JP6910305B2 JP6910305B2 (ja) | 2021-07-28 |
Family
ID=57143414
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017555218A Expired - Fee Related JP6910305B2 (ja) | 2015-04-20 | 2016-04-20 | 再生医療のためのベクターおよび方法 |
| JP2021045410A Active JP7325466B2 (ja) | 2015-04-20 | 2021-03-19 | 再生医療のためのベクターおよび方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021045410A Active JP7325466B2 (ja) | 2015-04-20 | 2021-03-19 | 再生医療のためのベクターおよび方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11331377B2 (enExample) |
| EP (2) | EP3285871B1 (enExample) |
| JP (2) | JP6910305B2 (enExample) |
| AU (2) | AU2016252619B2 (enExample) |
| CA (1) | CA2981811A1 (enExample) |
| DK (1) | DK3285871T3 (enExample) |
| ES (1) | ES2894673T3 (enExample) |
| HU (1) | HUE055902T2 (enExample) |
| PL (1) | PL3285871T3 (enExample) |
| PT (1) | PT3285871T (enExample) |
| WO (1) | WO2016172224A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109504710B (zh) * | 2018-12-04 | 2021-03-26 | 首都医科大学附属北京口腔医院 | Kdm4d的用途 |
| WO2023056456A1 (en) * | 2021-10-01 | 2023-04-06 | University Of Washington | Vectors and methods for improving cardiac regeneration |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090275099A1 (en) | 2004-04-27 | 2009-11-05 | Regents Of The University Of Michigan | Methods and compositions for treating diseases and conditions associated with mitochondrial function |
| EP2245140A2 (en) | 2007-11-30 | 2010-11-03 | New York Medical College | Compositions comprising hdac inhibitors and methods of their use in restoring stem cell function and preventing heart failure |
| WO2013155330A1 (en) * | 2012-04-11 | 2013-10-17 | University Of Massachusetts | Compositions and methods for characterizing and treating muscular dystrophy |
| US20150285802A1 (en) * | 2012-07-18 | 2015-10-08 | Dana-Farber Cancer Institute, Inc. | Methods for treating, preventing and predicting risk of developing breast cancer |
| US9144555B2 (en) * | 2012-11-30 | 2015-09-29 | Darlene E. McCord | Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition |
| WO2015048577A2 (en) * | 2013-09-27 | 2015-04-02 | Editas Medicine, Inc. | Crispr-related methods and compositions |
-
2016
- 2016-04-20 CA CA2981811A patent/CA2981811A1/en active Pending
- 2016-04-20 PT PT167837756T patent/PT3285871T/pt unknown
- 2016-04-20 WO PCT/US2016/028459 patent/WO2016172224A1/en not_active Ceased
- 2016-04-20 AU AU2016252619A patent/AU2016252619B2/en not_active Ceased
- 2016-04-20 EP EP16783775.6A patent/EP3285871B1/en active Active
- 2016-04-20 US US15/566,987 patent/US11331377B2/en active Active
- 2016-04-20 ES ES16783775T patent/ES2894673T3/es active Active
- 2016-04-20 DK DK16783775.6T patent/DK3285871T3/da active
- 2016-04-20 JP JP2017555218A patent/JP6910305B2/ja not_active Expired - Fee Related
- 2016-04-20 HU HUE16783775A patent/HUE055902T2/hu unknown
- 2016-04-20 PL PL16783775T patent/PL3285871T3/pl unknown
- 2016-04-20 EP EP21186914.4A patent/EP3936188B1/en active Active
-
2021
- 2021-03-19 JP JP2021045410A patent/JP7325466B2/ja active Active
- 2021-09-20 AU AU2021232850A patent/AU2021232850A1/en not_active Abandoned
-
2022
- 2022-04-18 US US17/659,598 patent/US20220249623A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lyu et al. | Macrophage-mediated regulation of catecholamines in sympathetic neural remodeling after myocardial infarction | |
| Karpov et al. | Can the outcomes of mesenchymal stem cell‐based therapy for myocardial infarction be improved? Providing weapons and armour to cells | |
| Rufaihah et al. | Dual delivery of VEGF and ANG-1 in ischemic hearts using an injectable hydrogel | |
| JP7693290B2 (ja) | Ｌａｒファミリーホスファターゼの活性を阻害する組成物及び方法 | |
| RU2014137169A (ru) | Системная доставка и регулируемая экспрессия паракринных генов для лечения сердечно-сосудистых и иных заболеваний | |
| Huang et al. | Time‐restricted release of multiple neurotrophic factors promotes axonal regeneration and functional recovery after peripheral nerve injury | |
| Crisostomo et al. | Dose-dependent improvement of cardiac function in a swine model of acute myocardial infarction after intracoronary administration of allogeneic heart-derived cells | |
| RU2012154574A (ru) | Способы и композиции для доставки в цнс арилсульфатазы а | |
| CA2982840A1 (en) | Methods of tissue repair and regeneration | |
| JP2016521708A5 (enExample) | ||
| Costa et al. | Neonatal injury models: integral tools to decipher the molecular basis of cardiac regeneration | |
| JP2014227368A (ja) | 糖尿病および高血糖状態の処置のためのグルカゴンアナログ | |
| JP2014506787A5 (enExample) | ||
| Legesse et al. | Neulasta regimen for the hematopoietic acute radiation syndrome: effects beyond neutrophil recovery | |
| Daneshi et al. | Cell-free treatments: a new generation of targeted therapies for treatment of ischemic heart diseases | |
| RU2017126212A (ru) | Композиция | |
| Wu et al. | Current perspectives on imaging cardiac stem cell therapy | |
| Altamirano et al. | Engineering the immune and fibrotic response in VML | |
| JP7450244B2 (ja) | 虚血組織を治療するための方法 | |
| Pesce et al. | Endothelial and cardiac progenitors: boosting, conditioning and (re) programming for cardiovascular repair | |
| Sun et al. | Therapeutic effects of intravenous administration of bone marrow stromal cells on sevoflurane-induced neuronal apoptosis and neuroinflammation in neonatal rats | |
| Thierry et al. | Cell therapy for the treatment of accidental radiation overexposure | |
| Xiao et al. | Biological approaches to generating cardiac biopacemaker for bradycardia | |
| CN110141682A (zh) | 一种负载外源干细胞的注射型胶原材料及其在心肌损伤修复中的应用 | |
| Tang et al. | Saikosaponin A ameliorates inflammatory response by modulating P38MAPK pathway in rats with depression and myocardial ischemia |